REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/03/2025
Back to search
Official data from USPTO
RELIXIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
11/04/2025
Trademark type
Combined
Nice classes
5
Filing date
12/19/2019
Registration date
11/03/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/03/2020
Last transaction
11/04/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
11/21/2018
First use in commerce
10/31/2019
Drawing code
3
Owner type
03
Owner location
Miami, FL
Examiner
NODES,CHRISTOPHER JAMES
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized word "RELIXIN", with the top left portion of the letter "X" consisting of broken diagonal lines and the lowercase "I"s framing the "X".
Holders and representatives
Holders
Ak Pharma, Inc.
Representatives
Peter A. Matos MALLOY & MALLOY, P.L.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations containing botulinum toxin type A for medical use for use in the treatment of wrinkles
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/03/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/18/2020
PUBO
PUBLISHED FOR OPPOSITION
08/18/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/29/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/14/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/26/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/26/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/26/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/19/2020
GNRT
NON-FINAL ACTION E-MAILED
03/19/2020
CNRT
NON-FINAL ACTION WRITTEN
03/19/2020
DOCK
ASSIGNED TO EXAMINER
03/17/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/31/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/28/2019
Continuous trademark protection
Get notified about every new filing that threatens RELIXIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.